1. Home
  2. DOMO vs ANIK Comparison

DOMO vs ANIK Comparison

Compare DOMO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$2.51

Market Cap

171.6M

Sector

Technology

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.12

Market Cap

198.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
ANIK
Founded
2010
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.6M
198.9M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
DOMO
ANIK
Price
$2.51
$14.12
Analyst Decision
Buy
Buy
Analyst Count
9
1
Target Price
$10.28
$17.00
AVG Volume (30 Days)
1.7M
49.0K
Earning Date
05-20-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
80.16
EPS
N/A
N/A
Revenue
$318,857,000.00
$112,819,000.00
Revenue This Year
$3.41
$5.98
Revenue Next Year
$4.72
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$7.90
52 Week High
$18.49
$16.24

Technical Indicators

Market Signals
Indicator
DOMO
ANIK
Relative Strength Index (RSI) 38.61 41.61
Support Level $2.39 $13.91
Resistance Level $4.07 $15.93
Average True Range (ATR) 0.39 0.48
MACD -0.16 -0.05
Stochastic Oscillator 23.68 26.12

Price Performance

Historical Comparison
DOMO
ANIK

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: